CompoAtlas

Olivino

Natural health product licensed in Canada

Licence holder
OlivinoLife Inc.
NPN or DIN-HM
80079534
Status
Active licence
Licence date
18 August 2017
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitis vinifera

Source : Vitis vinifera - Graine

Potency : 85 % Oligomeric proanthocyanidins

150 milligrammeNot calculated
trans-Resvératrol

Source : Resvératrol

30 milligrammeNot calculated
Olea europaea

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 14:1

Dry plant equivalent : 2.24 Grammes

160 milligrammeNot calculated
Lycopène

Source : Solanum lycopersicum - Chair (fruit)

10 milligrammeNot calculated

Non-medicinal ingredients

Tocophérols, Poudre de graines du pois chiche, Sirop de maïs séché, Amidon alimentaire, modifié, Ascorbate de sodium, Sucrose, Hydroxypropyl méthylcellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Capsule ; maximum: 3 Capsule1 day
AdultesNot specified1 Capsuleminimum: 1 day ; maximum: 3 days

Uses authorised in Canada

Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of antioxidants for the maintenance of good health. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. Helps to support prostate health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80079534

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line